DocGo Inc. (DCGO) discloses RSU grant and tax-related share sale

Rhea-AI Filing Summary

DocGo Inc. reported that director and officer Ely D. Tendler received 100,000 restricted stock units on December 12, 2025 under the company’s 2021 Stock Incentive Plan. These units vest in four equal annual installments on each of the first four anniversaries of that date, with each unit delivering one share of common stock when it vests.

On December 15, 2025, Tendler sold 16,850 shares of common stock at $0.91 to cover taxes due on vested units from earlier grants made in 2023 and 2024. After these transactions, he beneficially owned 258,795 DocGo shares and restricted stock units in total, including additional awards scheduled to vest in 2026 and 2027.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tendler Ely D

(Last) (First) (Middle)

C/O DOCGO INC.

685 THIRD AVENUE, 9TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DocGo Inc. [ DCGO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel and Secretary

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/12/2025		A		100,000(1)	A	$0	275,645(2)	D
Common Stock	12/15/2025		S		16,850(3)	D	$0.91	258,795(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). The RSUs will vest in four equal annual installments on each of the first four anniversaries of December 12, 2025, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.

2. In addition to the RSUs granted on December 12, 2025, this amount reflects (i) 48,449 RSUs granted pursuant to the Plan that will vest in two equal annual installments on each of December 12, 2026 and December 12, 2027; and (ii) 17,900 RSUs granted pursuant to the Plan that will vest on December 12, 2026, in each case subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.

3. The transaction reported reflects the disposition of Common Stock to cover taxes due in connection with the vesting of RSUs on December 12, 2025. The RSUs were granted to the Reporting Person on December 12, 2023 and December 12, 2024.

Remarks:

	/s/ Jerilyn Laskie, as Attorney-in-Fact for Ely D. Tendler	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DocGo (DCGO) disclose for Ely D. Tendler?

DocGo disclosed that director and officer Ely D. Tendler received 100,000 restricted stock units on December 12, 2025 and sold 16,850 shares of common stock on December 15, 2025.

How many RSUs did Ely D. Tendler receive and how do they vest at DocGo (DCGO)?

Tendler received 100,000 restricted stock units under DocGo’s 2021 Stock Incentive Plan. They vest in four equal annual installments on each of the first four anniversaries of December 12, 2025, with each unit converting into one share of common stock.

Why were 16,850 DocGo (DCGO) shares sold at $0.91?

The 16,850 shares of DocGo common stock sold at $0.91 on December 15, 2025 reflect a disposition to cover taxes due in connection with the vesting of restricted stock units on December 12, 2025 from grants made on December 12, 2023 and December 12, 2024.

What is Ely D. Tendler’s role at DocGo (DCGO)?

Ely D. Tendler serves as a director of DocGo Inc. and as an officer, holding the titles of General Counsel and Secretary.

How many DocGo (DCGO) securities does Ely D. Tendler beneficially own after these transactions?

Following the reported transactions, Ely D. Tendler beneficially owned 258,795 DocGo securities in total, which includes common stock and restricted stock units described in the filing.

What future RSU vesting is scheduled for Ely D. Tendler at DocGo (DCGO)?

Tendler’s future vesting includes the new 100,000 RSUs vesting in four equal annual installments from the anniversaries of December 12, 2025, plus 48,449 RSUs vesting in two equal annual installments on December 12, 2026 and December 12, 2027, and 17,900 RSUs vesting on December 12, 2026, all under DocGo’s 2021 Stock Incentive Plan.